Scaling New Heights: ICPL’s Vision of Expansion, Revenue Growth, and Excellence
Company Growth at a Glance
- Revenue Growth
“From Strength to Strength: A Remarkable Revenue Increase”
Revenue surged from Rs. 91.43 crores in fiscal 23 to Rs. 149 crores in fiscal 24, representing an impressive 63% growth, driven by volume expansion and customer acquisition.
Strategic Revenue Projections
- Future Revenue Goals
“Aiming High: Revenue Target for Fiscal 25”
ICPL is on track to reach revenue of Rs. 185-200 crores in fiscal 25 by tapping into the medical industry and leveraging existing customer relationships.
Expansion Plans
Manufacturing Expansion
“Investing for Tomorrow: Expanding into Injection Molding”
With an investment of Rs. 1-1.5 crore in fiscal 25, ICPL will begin manufacturing injection molding items, projected to generate an additional Rs. 5-6 crore annually.
Financial Performance & Margins
- Operating Margins Improvement
“Steady Progress: Operating Margins on the Rise”
Operating margins improved from 1.65% in fiscal 23 to 1.73% in fiscal 24, with a target of 3-4% in the medium term as ICPL enhances its manufacturing mix.
Investment Strategy
Capex Funding
The expansion will be funded by internal accruals and an infusion of Rs. 3.16 crore from promoters, ensuring smooth execution of our strategic plans.Focused Investment Approach
ICPL aims to optimize returns from its current investments, with no additional capital expenditure planned for the medium term.